FDA Issues Accelerated Approval Draft Guidance for Oncology

The FDA is looking for feedback on its newly published draft guidance on designing cancer drug trials intended for the accelerated approval pathway.
Medscape Medical News

source https://www.medscape.com/viewarticle/990242?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

New AAFP practice guideline sets blood pressure targets for adults with hypertension

Heart Failure Care Outside of ICU Can Lower Cost